Finzati - Logo
KMTS logo

Kestra Medical Technologies, Ltd.

KMTS • Medical - Instruments & Supplies
$28.15
▼ -0.13 (-0.44%)
Current price
EarningsLatest report: Jul 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.65B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 119.5%Manageable debt level · 0.18Healthy liquidity · 4.41Weak profitability
Financial data as of: Jul 31, 2026, 12:00 AM UTCLast earnings update: Jul 31, 2026, 12:00 AM UTCLast profile update: Sep 16, 2026, 12:05 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$28.15
Change-0.44%
Shares Out58.57M
Market Cap$1.65B
Enterprise Value$1.45B
52W Range17.34 - 30.00
Beta0.62
P/E-11.00
P/S15.45
P/B7.42
P/FCF-13.43
EV/Sales13.62

Investment DNA

How strong this company looks for long-term investors

46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
42/100
Why this score▼
Positive revenue growth · 119.5%Manageable debt level · 0.18Healthy liquidity · 4.41Weak profitability

Analyst view

Analyst sentiment and price target

KMTS
Analyst sentiment
Based on 4 analyst votes · 2026-10-20
88/100
Bullish
Bullish
3
Hold
1
Bearish
0
Price Target
2026-09-16
Low
$30.00
Mean
$30.67
Median
$30.00
High
$32.00

Company Overview

IPO: 3/6/2025
Industry: Medical - Instruments & Supplies
P/B i: 7.42
Debt / Equity i: 0.18
Operating Margin: -141.64%
Net Margin: -138.35%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.18
Current Ratio: 4.41
Quick Ratio: 4.28
Status: Good

Insider Transactions

Recent executive and insider activity

Ladone Mary Kay
Transaction: 09/09/2026
BUY
Change
+7,217
Price
Not reported
Filing
09/10/2026
Type
BUY
Reilly Kevin C
Transaction: 09/09/2026
BUY
Change
+7,217
Price
Not reported
Filing
09/10/2026
Type
BUY
Hanley Conor
Transaction: 09/09/2026
BUY
Change
+7,217
Price
Not reported
Filing
09/10/2026
Type
BUY